COVID Vaccine Distribution: Govt disagrees with Rs 80,000 Crore figure given by Serum Institute

Published On 2020-10-01 04:15 GMT | Update On 2020-10-01 04:15 GMT

New Delhi: The government on Tuesday said it does not agree with the calculation that Rs 80,000 crore is needed for distribution of COVID-19 vaccine in India. Health Ministry Secretary Rajesh Bhushan was responding to a question tweeted by Serum Institute of India Chief Executive Officer Adar Poonawalla who asked the government whether it had Rs 80,000 crore over the next one year for distribution of COVID-19 vaccine.

"Quick question; will the government of India have 80,000 crores available, over the next one year? Because that's what @MoHFW_INDIA needs, to buy and distribute the vaccine to everyone in India. This is the next concerning challenge we need to tackle," Poonawalla had tweeted.

Responding, Bhushan said, "We do not agree by the calculation of Rs 80,000 crore. The government has made a national committee on vaccine experts and five meetings have taken place till now."

"In these meetings, we have mulled over the process of COVID-19 vaccine distribution and the amount required for it in terms of prioritisation of population and the staggered immunisation for this prioritisation.

"We have calculated the amount required in the meetings and currently, that amount is available with the government," said Bhushan. UZM PLB AAR

Read also: Serum Institute to develop 200 million doses of COVID vaccine

Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

COVID Vaccine Distribution: Govt disagrees with Rs 80,000 Crore figure given by Serum Institute

Similar News

Shilpa Pharma Lifesciences Unit-1 successfully completes GMP inspection from Brazilian regulatory authority

Lupin rolls out Nasal spray for rhinorrhea relief in US

Pfizer Told To Conduct Phase IV Trial of Abrocitinib in Indian Adolescents with Atopic Dermatitis

CBI Cracks Down on PCI Chief Montu Patel in College Bribery Scandal

Submit Full Adverse Event Data from Lenvatinib Phase IV Liver Cancer Trial: CDSCO Panel To Eisai Pharma

Over 700 bottles of Codeine Cough Syrup seized, 2 arrested

Massive Rs 1.2 crore Oxytocin seizure in Lucknow, 3 held

High-Alcohol Medicinal Preparations to Come Under Schedule H1: Govt Panel Approves Rule Change